Target intelligence / Profile preview

Spindlin family member 4 (SPIN4)

Target
SPIN4
Molecular classification
Epigenetic reader, Chromatin-binding protein, Tudor domain–containing protein, Other
01

Overview

Spindlin family member 4 (SPIN4) is a nuclear protein belonging to the spindlin family, distinguished by containing three tandem Tudor-like domains that enable it to bind methylated lysine and arginine residues on histones, particularly H3K4me3 and H4K20me3[3][1][4]. SPIN4 operates primarily as an **epigenetic reader**, recognizing specific chromatin marks to mediate downstream gene regulation and cellular processes[1][3]. It is predominantly localized to chromatin and the nucleus[1][3]. Its best-defined biological roles include acting as a negative regulator of cell proliferation, promoting canonical Wnt/β-catenin signaling in certain contexts, and restraining somatic and organ growth, as demonstrated by the overgrowth phenotype seen in SPIN4 loss-of-function mutants in both human and mouse models[1]. SPIN4 does not appear to be a therapeutic target (e.g., receptor, enzyme, transporter) nor are there known drugs that act directly on SPIN4[3][1][4]. There is no current evidence for biomarker usage or specific safety concerns related to direct SPIN4 targeting. The mutant loss of SPIN4 is newly implicated in X-linked generalized overgrowth syndrome in humans, marking it as the first epigenetic reader gene implicated in such a disorder[1].

Other names
Spindlin-4FLJ44984TDRD28LJBSspindlin-4SPIN4
02

Biological functions

Recognition of methylated and acetylated histone marksNegative regulation of cell proliferationPromotion of canonical Wnt signaling (in the context of increased β-catenin)Regulation of body growth and organ sizeMaintenance of stem-like cells in the growth plate
03

Disease associations

Overgrowth syndromes (X-linked generalized overgrowth in humans and mice)Other (potential, but no established direct cancer or other disease role currently)

Beyond the preview

Go deeper on Spindlin family member 4 (SPIN4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spindlin family member 4 (SPIN4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call